Catherine Seibel

Jul 19, 2023 | law360.com | Scott D. Marty |William Rhodes |Catherine Seibel

By Scott Marty, William Rhodes and Catherine Seibel (July 19, 2023, 4:57 PM EDT) -- The life sciences industry may face a significant shift in the coming years in how research is funded and conducted due to a coalescence of factors within the industry and the broader economy.... Law360 is on it, so you are, too. A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence.

Jul 19, 2023 | ballardspahr.com | Scott D. Marty |William Rhodes |Catherine Seibel

A number of factors have led some industry participants and analysts to predict that the time is approaching when big pharma will not be generating the same level of new research and technology as in the recent past. So where can the life sciences industry look to find new research and technology? The answer may lie in a growing trend of partnerships with the education industry in the form of accelerators, incubator programs, and sponsored research.